Why the study?
How should patients with established cardiovascular disease be risk-stratified for physical activity clearance to minimize adverse events?
Population
Individuals with established cardiovascular disease (CVD) or at risk for CVD
Design
Guideline
Key result
Physical activity in clinically stable individuals with cardiovascular disease carries little risk of adverse events, prompting recommendations to update the PAR-Q and PARmed-X screening tools.
Authors
Loading...
Stable CVD patients warrant simplified activity clearance; confirms minimal risk and extends calls to update PAR-Q/PARmed-X.
Systematic Review
How should patients with established cardiovascular disease be risk-stratified for physical activity clearance to minimize adverse events?
Evidence-based recommendations support that clinically stable patients with CVD can safely participate in physical activity, suggesting updates to current screening tools like PAR-Q and PARmed-X.
Thomas et al. (2011) conducted a systematic review in Cardiovascular disease. Physical activity clearance recommendations was evaluated. Physical activity in clinically stable individuals with cardiovascular disease carries little risk of adverse events, prompting recommendations to update the PAR-Q and PARmed-X screening tools.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: